2
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
34
Squamous Cell Carcinoma of Head and Neck
22
Uterine Cervical Neoplasms
19
Lung Neoplasms
19
Small Cell Lung Carcinoma
16
Oropharyngeal Neoplasms
14
Ovarian Neoplasms
12
Carcinoma
10
Urinary Bladder Neoplasms
9
Stomach Neoplasms
9
Mouth Neoplasms
9
Laryngeal Neoplasms
9
Fallopian Tube Neoplasms
9
Hypopharyngeal Neoplasms
8
Cholangiocarcinoma
8
Pancreatic Neoplasms
7
Mesothelioma, Malignant
7
Medulloblastoma
7
Breast Neoplasms
7
Adenocarcinoma of Lung
7
Neuroblastoma
6
Nasopharyngeal Carcinoma
6
Gallbladder Neoplasms
6
Ganglioneuroblastoma
5
Brain Neoplasms
5
Triple Negative Breast Neoplasms
4
Prostatic Neoplasms
4
Lymphoid Interstitial Pneumonia
4
Head and Neck Neoplasms
4
Esophageal Neoplasms
4
Interventions
Vincristine
25
Cyclophosphamide
25
Irinotecan
21
Temozolomide
18
Doxorubicin
16
Radiotherapy
15
Filgrastim
15
Ifosfamide
14
Dactinomycin
14
Etoposide
11
Vinorelbine
9
Melphalan
9
Magnetic Resonance Spectroscopy
9
Granulocyte Colony-Stimulating Factor
9
Radiation
8
pegfilgrastim
7
X-Rays
7
Specimen Handling
7
Sirolimus
7
Topotecan
6
Phantoms, Imaging
6
Peripheral Blood Stem Cell Transplantation
6
Gemcitabine
6
cixutumumab
5
Busulfan
5
Biopsy
5
temsirolimus
4
irinotecan sucrosofate
4
fludarabine
4
etoposide phosphate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rhabdomyosarcoma
×
Platinum
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled